Related Experiment Video
Updated: Jul 15, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Senile panretinal cone dysfunction in age-related macular degeneration (AMD): a report of 52 amd patients compared to
Shawn Ronan1, Steve Nusinowitz, Anand Swaroop
1Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Purpose:
To test if patients with age-related macular degeneration (AMD) have normal panretinal function using standardized full-field electroretinograms (ERGs).
Methods:
This is a retrospective study evaluating electroretinographic studies performed in patients with AMD to assess their panretinal function. Fifty-two individuals 55 years or older had standardized ERG testing and fundus photographs.
Results:
The study group was aged 57 to 93 years old with a mean of 75.7, and the controls ranged from 79 to 87 years with a mean of 81.4. On average, the photopic, scotopic, dark-adapted bright-flash, and flicker function response amplitudes are lower with longer implicit times in the study group than the controls. The most pronounced differences were seen with the bright-flash dark-adapted a-waves and the photopic b-wave amplitudes. Forty-three of 104 eyes had abnormal photopic b-wave ERGs of more than 2 SD compared to controls. The mean of the photopic b-wave amplitudes for the study group was 76.7 +/- 36.2 muV (1 SD) compared to 91.4 +/- 16.9 muV (1 SD) for the control group. This finding was statistically significant with P = .0269 by the Student t test and P = .0336 by the Wilcoxon test.
Conclusions:
There is a subgroup of AMD patients with a panretinal cone dysfunction on ERG in association with their macular degeneration. Previous studies have shown varied results when looking at ERG changes in AMD, likely reflecting the underlying complexity of this disorder. Using standardized ERG to identify a more homogeneous subgroup of AMD patients with panretinal dysfunction will aid in better characterizing subtypes clinically and is likely to be valuable in identifying new genes contributing to AMD.
More Related Videos
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
08:54A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence
Published on: May 26, 2023